FDA ordered to reconsider denial of approval for vape products
Send a link to a friend
[January 04, 2024]
By Brendan Pierson
(Reuters) - A federal appeals court on Wednesday ordered the U.S. Food
and Drug Administration to reconsider its decision barring two makers of
flavored liquid for e-cigarettes from marketing their products, saying
the agency had been arbitrary and capricious in refusing to consider the
companies' marketing plans.
The 9-5 decision by the New Orleans-based 5th U.S. Circuit Court of
Appeals reversed a July 2022 decision by a three-judge panel of that
court.
Circuit Judge Andrew Oldham, who was appointed to the court by
Republican former president Donald Trump, wrote for the majority that
the FDA had first asked e-cigarette companies for detailed plans about
how they would market their products to prevent abuse by youth, saying
those plans were crucial, but then denied their applications without
looking at them. He said that fell short of the agency's obligation to
"turn square corners," or deal straightforwardly with companies.

"No principle is more important when considering how the unelected
administrators of the Fourth Branch of Government treat the American
people," he wrote, apparently likening executive branch agencies such as
the FDA to a separate branch of government. "And FDA's regulatory
switcheroos in this case bear no resemblance to square corners."
Eric Heyer, a lawyer for liquid makers Triton Distribution and Vapetasia
LLC, said he was pleased with the ruling and hoped it would lead the FDA
to make "a significant course correction by communicating with
specificity" what companies must do to get approval.
The FDA declined to comment.
The FDA in 2016 deemed e-cigarettes to be tobacco products like
traditional cigarettes subject to agency review under the Tobacco
Control Act, and said manufacturers of the products would need to apply
for approval to continue selling them.
[to top of second column]
|

Signage is seen outside of the Food and Drug Administration (FDA)
headquarters in White Oak, Maryland, U.S., August 29, 2020.
REUTERS/Andrew Kelly/File Photo
 It initially considered e-cigarettes
as having some promise in helping adult smokers transition from
conventional cigarettes, but faced pressure from anti-smoking groups
to restrict flavored e-cigarettes amid a rise in youth vaping.
Triton and Vapetasia had applied to market products with flavors
such as sour grape, pink lemonade, crème brulee and milk and cookies
and names including "Jimmy The Juice Man Strawberry Astronaut" and
"Suicide Bunny Bunny Season."
In a series of decisions beginning in 2021, the agency has rejected
more than a million applications, including Triton's and Vapetasia's,
finding no studies show the products have any benefit for adult
smokers. As of November, the FDA had approved only 23 e-cigarette
products, all tobacco flavored.
In a dissent on Wednesday, Circuit Judge Catharina Haynes wrote that
the FDA's decision was reasonable, since "even the most promising
plans" for marketing were "irrelevant" if the products had no
benefit for adults.
(Reporting By Brendan Pierson in New York, Editing by Alexia
Garamfalvi and Daniel Wallis)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |